BioSpain 2021


Pamplona will host the tenth edition of the BioSpain biotech conference in 2021

BIOSPAIN 2021 - Portada

In 2021, Navarra will host the tenth edition of the benchmark trade fair in the biotech sector, known as BioSpain. The Spanish Association of Biocompanies (AseBio) has chosen the capital of Navarra to gather together more than 1,500 professionals from the biotech sector who participate every year in what is considered the fifth largest biotech event in the world in terms of the number of business meetings it generates. The event will be held from 29 September to 1 October in the Palacio de Baluarte in Pamplona / Iruña.

The fair will host a commercial exhibition, plenary sessions, an investors’ forum and bilateral business meetings between professionals from biotech and pharmaceutical companies, research institutes, universities and clusters. The government of Navarra will participate in organising the event via Sodena, which will be the local partner for the BioSpain2021 event.

BioSpain will have different spaces where the latest biotech trends will be shared. Therefore, in addition to the commercial exhibition, different plenary sessions will be held by national and international speakers.

Likewise, an investors’ forum will be held to attract licensing teams from pharmaceutical companies and domestic and international venture capital firms, as well as bilateral business meetings to foster technology transfer, where universities and research centres can forge contacts industry.

The gatherings will bring together stakeholders like representatives of biotech and pharmaceutical companies, research institutes, universities, clusters, investors, consultancy services and medical tech companies.

The companies attending BioSpain, many of them biotech SMEs from Spain, not only manage to generate new business opportunities but also use it as an international exhibition platform where they can share their biotech capacities firsthand. In fact, in the survey administered to participants in the 2018 edition, 84.81% claimed that they had identified real business opportunities.